Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Cipher Pharmaceuticals Inc T.DND

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  CPHMF

Cipher Pharmaceuticals Inc is a specialty commercial stage pharmaceutical company. It focuses on development and commercialization of novel formulations of currently marketed molecules using advanced drug delivery technologies.
Price: $9.09 | Change: +$0.14 | %Change: +1.56%
Volume: 39,247 | Day High/Low: 9.18/8.95 | 52 Week High/Low: 9.59/6.00


View modes: 
0 stars

Ranbaxy gains after inking licensing pact with Cipher

http://www.indiainfoline.com/Markets/News/Ranbaxy-gains-after-inking-licensing-pact-with-Cipher/5474471387   Ranbaxy gains after inking licensing pact with Cipher     Capital Market...read more
0 stars

RE:Decent Earnings but didn't like that Absorica sold less this

Ranbaxy just got a new owner, so who knows how this affected the Absorbica sales force in the USA. Lets hope the new ownners of Ranbaxy have not decided to fix something (the Absorbica sales force...read more
5 stars

Decent Earnings but didn't like that Absorica sold less this

Q then last Q by $200K or so. We'll have to see what happens in the next Q, and if it's down for a third Q that would be a bad sign.  rate and reply
4 stars

RE:q and future ok

good quarter just about on every front, incease market share for their products continue, good to see their oher pruducts bring in some good revenue, and talk of expanding their product line...read more
5 stars

q and future ok

Cipher reports financial results for Q2 2014 2 hours 2 minutes ago Like 0 ...read more
4 stars

brazilian breakdown

Based on prescription data from IMS Health, approximately 36 million isotretinoin capsules were dispensed to patients in 2012 (the most recent year for which we have data) ·         The pricing of...read more
0 stars

Looks like Cipher will be tesing the all time hig very soon

Yup insiders knew something. Where are all the bashers now?? They called asking for the facts pumping, because they could not find any real bad news for Cipher. Lets hope Cipher will make marketing...read more
2.5 stars

RE:news

Hey Dave question for you, do you think it is a typo they say the market is 50 million$. Seems rather low for a population that size?  rate and reply
5 stars

news

Cipher Pharmaceuticals and Ranbaxy Announce Distribution Agreement for Isotretinoin Product in Brazil 37 minutes ago...read more
0 stars

looks like Cipher will test its all time high very soon

Insiders know something again?? Running out of sellers at these levels? If Cipher can beat its all time high, look for a big breakout after that with continued good news on sales and profits  rate and reply
0 stars

Notice of Cipher Q2 2014 Conference Call with link

[That day trader Smush never wants to include links because he sometimes will add in some lies which don't hold up well when easily checked against a link to the original article http://web.tmxmoney...read more
3.5 stars

Cipher Pharmaceuticals Inc. Q2 2014 Conference Call

Q2 2014 CONFERENCE CALL WHEN: Wednesday, July 30, 2014 at 8:30AM ET CONFERENCE CALL/WEBCAST: You can join the call by dialing 647-427-7450 or 1-888-231-8191. A live audio webcast will be available...read more
2.5 stars

RE:RE:RE:RE:Cipher would be $40-$60 if it was on the Nasdaq

Yes it is nice to have lots of different drugs but they must be drugs that do well. How many small pharma companies have a drug that is doing as well as Absorbica? Its better to have one big drug than...read more
3.5 stars

RE:RE:RE:Cipher would be $40-$60 if it was on the Nasdaq

Hardly. But it is undervalued nevertheless. Another product or two would really move the market cap.  rate and reply
2.5 stars

Great posts yasman, peterpanda and stock itch

I like the links and facts being discusssed. You are all right, there are are many companies with much higher valuations than Cipher that are losing money with massive debts and no chance to make...read more
4 stars

Doug Loe on BNN

Doug Loe, one of the analysts covering Cipher, was on BNN this morning and spoke about DND.  Here is the link, he was a guest at 10:35 am. http://www.bnn.ca/Shows/Business-Day.aspx  rate and reply
4 stars

Blog about Donville

Just take a look at this blog about Donville. There is a post about some positions of his fund. I'm pretty sure the guy is gonna talk about Cipher soon. www.dontfuc*withdonville.blogspot.ca Just...read more
2.5 stars

RE:RE:Cipher would be $40-$60 if it was on the Nasdaq

From what I understood they had 3 products, although nothing wrong with 1 so long as it is best of breed, just ask QCOR or JAZZ. Both were penny stocks and each have 1 high selling product only. They...read more
3.5 stars

RE:RE:RE:Cipher would be $40-$60 if it was on the Nasdaq

the thing is they don't own the whole package 100% it is divided three ways right now for the US market, their share is 7.5%.  Either way the quarter is coming to a end they have a new CEO so we shall...read more
2.5 stars

RE:RE:Cipher would be $40-$60 if it was on the Nasdaq

From what I understood they had 3 products, although nothing wrong with 1 so long as it is best of breed, just ask QCOR or JAZZ. Both were penny stocks and each have 1 high selling product only. They...read more